Loading viewer...
earnings
Format: PDF earnings
J.P. Morgan equity research alert on OPKO's phase 3 study of hGH-CTP in adults with growth hormone deficiency, which failed to meet its primary endpoint on trunk fat mass reduction. Despite the disappointing adult results, the company initiated its pediatric phase 3 study, which represents approximately 75% of the total market opportunity.
investor_presentation
27 Pages
OPKO Health Investor Presentation — September 2017
investor_presentationinvestor_presentation
23 Pages
earnings
34 Pages
Alma Media
Samvardhana Motherson Automotive FY2022 Financial Results
earningsearnings
20 Pages
Samvardhana Motherson Automotive Systems Group
Blackstone Mortgage Trust 2022 Q4 & Full Year Earnings Results
earningsearnings
20 Pages
Blackstone Mortgage Trust